Keros Therapeutics, Inc. short interest in 2020
In 2020, Keros Therapeutics, Inc.'s disclosed short interest ran from 3.58% of shares outstanding on 15 Jul 2020 to 4.54% on 31 Dec 2020, a change of +0.96 percentage points. The year's high was 6.42% on 14 Aug 2020 and its low 2.30% on 15 Dec 2020, averaging 4.06% across 11 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.11 days on 15 Sep 2020. Full history: Keros Therapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 3.58% (15 Jul 2020)
- End of year
- 4.54% (31 Dec 2020)
- Change
- +0.96 pp
- High
- 6.42% (14 Aug 2020)
- Low
- 2.30% (15 Dec 2020)
- Average
- 4.06%
- Highest days to cover
- 16.11 (15 Sep 2020)
- SEC filings marked
- 6
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jul 2020 | 3.58% | 10.71 | 10-Q filed, results (8-K) |
| 31 Jul 2020 | 5.22% | 11.26 | |
| 14 Aug 2020 | 6.42% | 14.89 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 5.38% | 11.00 | |
| 15 Sep 2020 | 4.35% | 16.11 | |
| 15 Oct 2020 | 3.21% | 3.48 | |
| 30 Oct 2020 | 3.87% | 6.82 | |
| 13 Nov 2020 | 3.12% | 6.85 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 2.64% | 2.43 | |
| 15 Dec 2020 | 2.30% | 2.80 | |
| 31 Dec 2020 | 4.54% | 3.69 |
See also: Keros Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.